机器学习对卵巢癌中金化疗反应的预测价值:系统审查和元分析
Qingyi Wang1, Zhuo Chang2, Xiaofang Liu1
1Department of First Clinical Medical College, Heilongjiang University of Chinese Medicine, Harbin, China.
Journal of medical Internet research
|January 22, 2024
概括
机器学习模型在预测卵巢癌对化疗反应方面表现有前途. 这一系统性审查证实了它们的有效性,表明了改善临床评分系统的潜力.
科学领域:
- 在瘤学瘤学.
- 医疗信息学 医疗信息学
- 生物统计学 生物统计学
背景情况:
- 卵巢癌的治疗通常涉及基于的化疗.
- 预测患者对这种治疗的反应对于个性化治疗策略至关重要.
- 机器学习 (ML) 提供了预测治疗结果的潜力,但其有效性需要系统评估.
研究的目的:
- 系统地审查关于ML对卵巢癌患者基于的化疗反应的预测价值的文献.
- 评估不同的ML模型在预测治疗结果方面的表现.
主要方法:
- 在PubMed,Embase,Web of Science和Cochrane数据库的系统文献搜索 (2023年4月26日之前).
- 包括的研究评估了ML模型,用于预测卵巢癌中基于的治疗反应.
- 使用预测模型偏差风险评估工具评估偏差风险.
- 模型性能使用一致性指数 (C指数),灵敏度和特异性进行评估.
主要成果:
- 从1749篇最初的文章中,包括了39个模型的19项研究.
- 逻辑回归 (41%),极端梯度提升 (10%) 和支持向量机 (SVM) (10%) 是常见的方法.
- 聚合的C指数为0.806 (培训) 和0.831 (验证).
- SVM表现出高性能 (C指数为0.942培训,0.879验证);聚合灵敏度为0.890,特异性为0.790 (培训).
结论:
- 机器学习模型可以有效地预测患者对卵巢癌基化疗的反应.
- 这些发现支持在开发和完善卵巢癌治疗临床评分系统时使用ML.
- 基于ML的预测为未来的临床决策和治疗优化提供了宝贵的参考.
更多相关视频
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
8.3K
07:15Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
Published on: August 16, 2020
6.8K
相关概念视频
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cancer Survival Analysis
353
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
353
